April 26, 2026 Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes
April 26, 2026 ZONE Investors Have Opportunity to Join CleanCore Solutions, Inc. Fraud Investigation with the Schall Law Firm
April 26, 2026 APUS Investors Have Opportunity to Join Apimeds Pharmaceuticals US, Inc. Fraud Investigation with the Schall Law Firm
April 26, 2026 C3 Davos of Healthcare™ Silicon Valley Summit Kicks Off Tomorrow in Sunnyvale, Powered by Global Partnership with KFSH
